Abstract
Background
Dry eye syndrome (DES) is a common tear film and ocular surface disease that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. Systemic diseases associated with DES include diabetes mellitus, rheumatoid arthritis, depression, anxiety, thyroid disease, allergic diseases, irritable bowel syndrome, chronic pain syndrome, and hyperlipidemia. Interestingly, it has been found that most of these are associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) or inadequate sunlight exposure.
Methods
In this cross-sectional data analysis, noninstitutionalized adults aged ≥19 years (N = 17,542) who participated in Korean National Health and Nutrition Examination Survey 2010–2012 were included. Information regarding duration of sunlight exposure was collected from the survey participants. Serum 25(OH)D and zinc levels were measured. The confounding variables were age, gender, sunlight exposure time, region of residence, obesity, serum 25(OH)D level, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and walking exercise.
Results
Mean serum 25(OH)D levels of subjects with and without DES were 16.90 ± 6.0 and 17.52 ± 6.07 (p<0.001). Inadequate sunlight exposure time (odds ratio [OR], 1.554; 95% confidence interval [CI], 1.307–1.848), urban residence (OR, 1.669; 95% CI, 1.456–1.913), indoor occupation (OR, 1.578; 95% CI, 1.389–1.814), and low serum 25(OH)D level (OR, 1.158; 95% CI, 1.026–1.308) were the risk factors for DES. After adjusting for age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and occupation, low serum 25(OH)D level (OR, 1.178; 95% CI, 1.010–1.372) and deficient sunlight exposure time (OR, 1.383; 95% CI, 1.094–1.749) were the risk factors for diagnosed DES.
Conclusion
Low serum 25(OH)D levels and inadequate sunlight exposure are associated with DES in Korean adults. These results suggest that sufficient sunlight exposure or vitamin D supplementation may be useful in DES treatment.
Introduction
Dry eye syndrome (DES) is a common tear film and ocular surface disease that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface [1]. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface [1]. DES significantly affects the quality of life owing to symptoms of pain and irritation [2]. Inflammation is recognized to play an important role in the pathogenesis of DES [3]. Chronic inflammation stimulated by the activation of innate immune components in ocular surface cells as well as increased tear osmolarity has been involved in DES [4]. DES is a multifactorial disease associated with systemic as well as local disease [1]. Blepharitis, meibomian gland dysfunction, eyelid deformity, and conjunctivochalasis are known risk factors for DES. Systemic diseases associated with DES include diabetes mellitus, rheumatoid arthritis, depression, anxiety, thyroid disease, allergic diseases, irritable bowel syndrome, chronic pain syndrome, and hyperlipidemia [5–9]. Interestingly, it has been found that most of these are associated with low levels of serum 25-hydroxyvitamin D (25(OH)D) or inadequate sunlight exposure [10–17].
Vitamin D is produced during exposure to sunlight, and is known to regulate calcium and phosphate homeostasis [10]. However, vitamin D receptor has been discovered in most tissues and cells in human body, including corneal epithelial cells [18], salivary glands [19,20], mammary glands [10], sebaceous glands [21], and immune cells [10]. Vitamin D has been suggested to play an essential role in these organs. Low serum vitamin D levels have been reported to be associated with obesity, diabetes mellitus, inflammatory bowel disease, atopic dermatitis, depression and autoimmune diseases [11–17]. Vitamin D exerts modulating effects on the immune response of both the innate and adaptive immune systems [22]. Furthermore, the active metabolite of 25(OH)D, 1, 25-dihydroxyvitamin D, has been found to regulate cytokine production and cell proliferation [23]. Serum 25(OH)D levels have been reported to be the most accurate way to measure vitamin D status statusthe body. In the kidney, 25-hydroxy vitamin D changes into an active form of the vitamin D, 1, 25-dihydroxyvitamin D [17]. A few studies have reported the association between serum vitamin D levels and dry eye syndrome has been reported [24,25]. However, those studies has a limitation of small sample size. The association of serum vitamin D levels and sunlight exposure time on DES have not been sufficiently evaluated.
In this study, we used the Korean National Health and Nutrition Examination Survey (KNHANES) to investigate the association of vitamin D deficiency and sunlight exposure time on DES in large population.
Methods
Study population
The Korean National Health and Nutrition Examination Survey (KNHANES) is a series of cross-sectional surveys of nationally representative samples of the civilian Korean population aged 1 year and older that are conducted annually to assess the health and nutrition status of the South Korean population. To obtain representative samples, the KNHANES uses a stratified, multistage, cluster probability sampling design according to geographical area, age, and gender. More details regarding the sampling method are provided elsewhere [11]. The main components of the overall KNHANES survey are a health interview, health examination survey, and nutrition survey. For the health interview survey, a trained interviewer asked questions directly to individuals aged ≥19 years. This study included 17,542 adults (7,434 men and 10,108 women) aged ≥19 years who met the eligibility criteria and who completed a questionnaire regarding independent risk factors and underwent slit-lamp examinations.
Ethics statement
The KNHANES was approved by the Korean Centers for Disease Control and Prevention Institutional Review Board, and all participants provided written informed consent. This study adhered to the tenets of the Declaration of Helsinki.
Data collection and diagnostic criteria
For accurate data collection, participants were asked whether they have had DES symptoms (self-reported) and whether they have been previously diagnosed with DES. Subjects were asked the following question: “Until now, have you ever had dry eye symptoms before; for example, dryness of the eye or a sense of irritation?” (symptoms of DES; sxDES) Then, the subjects were asked: “To date, have you ever before been diagnosed by a physician as having a dry eye (either eye)?; emphasis was placed on the phrase ‘‘by a physician”[26]. The possible responses to the question about a previous diagnosis were “No” or “Yes” (diagnosed DES; dgDES). Data collected by the 2010–2012 KNHANES were analyzed in the present study.
Variables
The population was divided according to residential area: rural or urban. Occupation was classified on the basis of Korean Standard Classification of Occupations as follows: group 1 (managers, professionals, and related workers); group 2 (clerks); group 3 (service and sales workers); group 4 (skilled agricultural, forestry, and fishery workers); group 5 (craft, equipment, and machine operating and assembling workers); group 6 (elementary workers); and group 7 (housewives, students, and the unemployed). In this study, groups 1, 2, 3, and 7 were merged into a single group (indoor occupation) and groups 4, 5, and 6 (outdoor occupation) also were merged, because the latter groups were reported previously to have significantly higher serum 25(OH)D levels than the former groups [11]. Obesity was defined as body mass index over 30 kg/m2. Diabetes mellitus was defined as fasting plasma glucose 125 mg/dL and impaired fasting glucose as fasting plasma glucose 110 mg/dL [27]. Participants were asked whether they had had rheumatoid arthritis, depression, thyroid disease, atopic dermatitis, or ocular surgery. Participants who performed moderate physical activity for more than 30 min per day on more than 5 days per week and/or strenuous physical activity for more than 20 min per day on more than 3 days per week were assigned to the regular exercise group. Regular walking was defined as walking for more than 30 min per day on more than 5 days per week, as described previously [12,14]. Data on current sunlight exposure time was obtained by selecting a single answer to the following two questions: exposure time of under 5 h, or over 5 h a day.
Measurement of serum 25-hydroxyvitamin D and zinc levels
Blood samples were collected from the antecubital veins, refrigerated immediately, transported to the central testing facility in cold storage, and analyzed within 24 h of sampling. Serum 25(OH)D levels were measured as described previously [13] and categorized as adequate (>20 ng/mL), inadequate (range, 12 to <20 ng/mL), or deficient (<12 ng/mL), according to the guidelines set by the Food and Nutrition Board of the Institute of Medicine [28].
Statistical analyses
Statistical analyses were performed by using the SPSS Version 18.0 (SPSS Inc., IBM Software, Portsmouth, UK), and 2-sided P-values of less than .05 were considered statistically significant. To produce unbiased national estimates representing the general Korean population, we used KNHANES sample weights accounting for the complex sampling design to each participant [29].
Chi-square test was used for comparison of discrete variables between groups. Student's t-test for independent samples was used for comparison of the differences between groups. The percentage differences were calculated as the absolute value of the change in value, divided by the average of the 2 numbers, all multiplied by 100. To estimate odds ratios (ORs) of dgDES and sxDES according to serum vitamin D levels, we conducted the logistic regression analyses by using the generalized linear model for a complex survey design. The ORs and 95% confidence intervals (CIs) were calculated in the following ways: no adjustment for potential confounders; confounder adjustment for age and gender.
Results
General characteristics
Characteristics of the study population are shown in Table 1. Mean age of the complete study population was 50.88 ± 16.67 years. The overall prevalence of dgDES was 10.39% (95% CI, 9.93% to 10.84%), and the prevalence of sxDES in the past 3 months was 17.79% (95% CI, 17.21% to 18.36%). Mean age among participants with dgDES (51.64 ± 16.28 years) was higher compared with non-dgDES (50.79 ± 16.71 years; p = 0.004, independent t-test). Pearson χ2 test showed significant differences between age, gender, residential region, occupation, rheumatoid arthritis, depression, thyroid disease, history of ocular surgery, regular exercise, serum 25(OH)D levels, sunlight exposure time, and dgDES. In contrast to the factors that were associated with dgDES, those that were associated with sxDES were age, gender, residential region, occupation, depression, thyroid disease, history of ocular surgery, regular exercise, walking exercise, serum zinc levels, serum 25(OH)D levels, and sunlight exposure time (Table 1).
Table 1. General characteristics of dry eye syndrome.
Diagnosed DES (dgDES) | Symptoms of DES (sxDES) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Non-dgDES | dgDES | %difference | p-value | Non-sxDES | sxDES | %difference | p-value | ||||
Total | |||||||||||
N (%) | 15720 (89.61%) | 1822 (10.39%) | 13948 (82.21%) | 3018 (17.79%) | |||||||
Age (y) | <0.001* | <0.001* | |||||||||
<50 | 3453 (92.62%) | 275 (7.38%) | 6890 (83.28%) | 1383 (16.72%) | |||||||
≥50 | 12267 (88.80%) | 1547 (11.20%) | 41.12 | 7058 (81.19%) | 1635 (18.81%) | 11.76 | |||||
Gender | <0.001* | <0.001* | |||||||||
Male | 7023 (94.47%) | 411 (5.53%) | 6343 (88.50%) | 824 (11.50%) | |||||||
Female | 8697 (86.04%) | 1411 (13.96%) | 86.51 | 7605 (77.61%) | 2194 (22.39%) | 64.27 | |||||
Obesity | 0.430 | 0.058 | |||||||||
Non-obese | 7702 (89.88%) | 869 (10.12%) | 6868 (82.83%) | 1424 (17.17%) | |||||||
Obese | 3594 (89.40%) | 426 (10.60%) | 4.63 | 3160 (81.42%) | 721 (18.58%) | 7.89 | |||||
Diabetes mellitus | 0.713 | 0.927 | |||||||||
Non-DM | 10078 (89.57%) | 1174 (10.43%) | 8935 (82.21%) | 1933 (17.79%) | |||||||
IFG | 2681 (89.70%) | 308 (10.30%) | 1.25 | 2381 (82.10%) | 519 (17.90%) | 0.62 | |||||
DM | 1486 (90.22%) | 161 (9.78%) | 6.43 | 1316 (82.56%) | 278 (17.44%) | 1.99 | |||||
Rheumatoid arthritis | <0.001* | 0.051 | |||||||||
Non-RA | 14909 (89.75%) | 1702 (10.25%) | 13218 (82.26%) | 2851 (17.74%) | |||||||
RA | 368 (84.21%) | 69 (15.79%) | 42.55 | 330 (78.57%) | 90 (21.43%) | 18.84 | |||||
Depression | <0.001* | <0.001* | |||||||||
Non-depression | 13068 (90.40%) | 1387 (9.60%) | 11659 (83.42%) | 2317 (16.58%) | |||||||
Depression | 2210 (85.20%) | 384 (14.80%) | 42.62 | 1889 (75.17%) | 624 (24.83%) | 39.85 | |||||
Thyroid disorder | <0.001* | <0.001* | |||||||||
Non-thyroid disorder | 14710 (90.02%) | 1630 (9.98%) | 13054 (82.59%) | 2752 (17.41%) | |||||||
Thyroid disorder | 567 (80.08%) | 141 (19.92%) | 66.49 | 493 (72.29%) | 189 (27.71%) | 45.66 | |||||
History of ocular surgery | <0.001* | <0.001* | |||||||||
No | 13435 (91.02%) | 1326 (8.98%) | 11999 (84.00%) | 2285 (16.00%) | |||||||
Yes | 2130 (81.86%) | 472 (18.14%) | 67.55 | 1831 (72.72%) | 687 (27.28%) | 52.12 | |||||
Atopic dermatitis | 0.634 | 0.187 | |||||||||
Non-AD | 14590 (89.64%) | 1687 (10.36%) | 12944 (82.25%) | 2793 (17.75%) | |||||||
AD | 688 (89.12%) | 84 (10.88%) | 4.90 | 604 (80.32%) | 148 (19.68%) | 10.31 | |||||
Region of residence | <0.001* | <0.001* | |||||||||
Urban | 12267 (88.80%) | 1547 (11.20%) | 10933 (81.67%) | 2453 (18.33%) | |||||||
Rural | 3453 (92.62%) | 275 (7.38%) | 41.12 | 3015 (84.22%) | 565 (15.78%) | 14.95 | |||||
Occupation | <0.001* | <0.001* | |||||||||
Indoor | 11091 (88.30%) | 1470 (11.70%) | 9821 (80.86%) | 2325 (19.14%) | |||||||
Outdoor | 4128 (93.29%) | 297 (6.71%) | 54.21 | 3676 (85.83%) | 607 (14.17%) | 29.84 | |||||
Sunlight exposure time (h) | <0.001* | <0.001* | |||||||||
Sufficient (≥ 5) | 2194 (93.24%) | 159 (6.76%) | 1906 (84.34%) | 354 (15.66%) | |||||||
Inadequate (2–5) | 3707 (90.68%) | 381 (9.32%) | 31.84 | 3292 (83.32%) | 659 (16.68%) | 6.31 | |||||
Deficient (< 2) | 9790 (88.45%) | 1278 (11.55%) | 52.32 | 8722 (81.35%) | 2000 (18.65%) | 17.43 | |||||
Regular exercise | 0.043* | 0.014* | |||||||||
No | 13929 (89.44%) | 1644 (10.56%) | 12336 (81.93%) | 2721 (18.07%) | |||||||
Yes | 1318 (91.15%) | 128 (8.85%) | 17.62 | 1182 (84.55%) | 216 (15.45%) | 15.63 | |||||
Walking exercise | 0.062 | 0.048* | |||||||||
No | 9431 (89.24%) | 1137 (10.76%) | 8340 (81.68%) | 1871 (18.32%) | |||||||
Yes | 5800 (90.15%) | 634 (9.85%) | 8.83 | 5164 (82.90%) | 1065 (17.10%) | 6.89 | |||||
Serum zinc level (μg/dL) | 0.091 | 0.004* | |||||||||
>110 | 742 (45.00%) | 907 (55.00%) | 624 (79.29%) | 163 (20.71%) | |||||||
<110 | 89 (51.74%) | 83 (48.26%) | 13.05 | 801 (84.67%) | 145 (15.33%) | 29.86 | |||||
Serum 25(OH)D level (ng/mL) | <0.001* | 0.001* | |||||||||
Adequate (≥20) | 4390 (91.29%) | 419 (8.71%) | 3866 (83.68%) | 754 (16.32%) | |||||||
Inadequate (12–20) | 7892 (89.38%) | 938 (10.62%) | 19.76 | 7071 (82.35%) | 1516 (17.65%) | 7.83 | |||||
Deficient (<12) | 2601 (60.39%) | 1706 (39.61%) | 127.89 | 2271 (80.13%) | 563 (19.87%) | 19.62 |
*statistically significant by chi-square test
DES = dry eye syndrome; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
In a binary logistic regression analysis, the risk factors for dgDES included older age (odds ratio [OR], 1.179; 95% confidence interval [CI], 1.070–1.300), female gender (OR, 2.772; 95% CI, 2.473–3.108), rheumatoid arthritis (OR, 1.642; CI, 1.264–2.134), depression (OR, 1.637; 95% CI, 1.450–1.849), thyroid disease (OR, 2.244; 95% CI, 1.853–2.718), history of ocular surgery (OR, 1.284; 95% CI, 1.166–1.414), urban residence (OR, 1.583; 95% CI, 1.385–1.810), indoor occupation (OR, 1.841; 95% CI, 1.618–2.096), low serum 25(OH)D levels (<20 ng/mL; OR, 1.280; 95% CI, 1.139–1.439), and inadequate sunlight exposure time (OR, 1.696; 95% CI, 1.433–2.008). Regular exercise (OR, 0.823; 95% CI, 0.681–0.994) was a protective factor for dgDES. The risk factors for sxDES included older age (OR, 1.154; 95% CI, 1.066–1.249), female gender (OR, 2.221; 95% CI, 2.036–2.422), depression (OR, 1.662; 95% CI, 1.503–1.839), thyroid disease (OR, 1.818; 95% CI, 1.530–2.161), history of ocular surgery (OR, 1.099; 95% CI, 1.035–1.166), urban residence (OR, 1.197; 95% CI, 1.083–1.323), indoor occupation (OR, 1.433; 95% CI, 1.300–1.580), serum 25(OH)D levels (<12 ng/mL; OR, 1.271; 95% CI, 1.126–1.434), <110 μg/dL zinc levels (OR, 1.443; 95% CI, 1.127–1.848), and inadequate sunlight exposure time (OR, 1.696; 95% CI, 1.433–2.008). Regular exercise (OR, 0.828; 95% CI, 0.712–0.963) and walking exercise (OR, 0.919; 95% CI, 0.846–0.999) were the protective factors for sxDES.
Differences in mean serum 25-hydroxtvitamin D and zinc levels based on the presence of DES
From this adult Korean population, we determined whether serum levels of 25(OH)D or zinc correlated with dgDES or sxDES by comparing the estimated mean values. Without adjusting for potential confounders, the mean 25(OH)D levels were significantly lower in participants with dgDES or sxDES (p < 0.001 for both, independent t-test; Table 2). The mean serum zinc level was not different in participants with dgDES, but it was lower in participants with sxDES (p = 0.001, Table 2).
Table 2. Serum 25(OH)D levels and zinc levels between groups.
Diagnosed DES (dgDES) | Symptoms of DES (sxDES) | |||||
---|---|---|---|---|---|---|
Non-dgDES | dgDES | p-value | Non-sxDES | sxDES | p-value | |
Serum 25(OH)D level (ng/mL) | 17.52 ± 6.07 | 16.90 ± 6.08 | <0.001* | 17.51 ± 6.03 | 17.12 ± 6.13 | 0.001* |
Serum zinc levels (μg/dL) | 136.05 ± 29.58 | 131.80 ± 25.79 | 0.070 | 137.09 ± 29.45 | 131.20 ± 28.63 | 0.001* |
*statistically significant by independent t-test
25-hydroxyvitamin D = 25(OH)D; DES = dry eye syndrome
Serum 25(OH)D levels were lower in participants with the following characteristics: younger age, female gender, non-diabetes mellitus, rheumatoid arthritis, no history of ocular surgery, atopic dermatitis, urban residence, indoor occupation, low serum zinc levels, or inadequate sunlight exposure time (p < 0.001 for all except for rheumatoid arthritis, p = 0.041 for rheumatoid arthritis, independent t-test; Table 3) and higher in participants with regular exercise or walking exercise (p < 0.001 for both; Table 3).
Table 3. Serum 25(OH)D level (ng/mL).
Serum 25(OH)D level (ng/mL) | p-value | |
---|---|---|
Age (y) | <0.001* | |
<50 | 16.25 ± 5.26 | |
>50 | 18.70 ± 6.46 | |
Gender | <0.001* | |
Male | 18.45 ± 5.97 | |
Female | 16.49 ± 5.80 | |
Obesity | 0.660 | |
Non-obese | 17.37 ± 5.95 | |
Obese | 17.32 ± 6.02 | |
Diabetes mellitus | <0.001* | |
Non-DM | 17.20 ± 5.94 | |
IFG | 18.19 ± 6.09 | |
DM | 18.25 ± 6.65 | |
Rheumatoid arthritis | 0.041* | |
Non-RA | 17.46 ± 6.06 | |
RA | 18.15 ± 6.72 | |
Depression | 0.718 | |
Non-depression | 17.49 ± 6.01 | |
Depression | 17.44 ± 6.18 | |
Thyroid disorder | 0.405 | |
Non-thyroid disorder | 17.47 ± 6.06 | |
Thyroid disorder | 17.67 ± 6.31 | |
History of ocular surgery | <0.001* | |
No | 17.39 ± 5.99 | |
Yes | 17.91 ± 6.58 | |
Atopic dermatitis | <0.001* | |
Non-AD | 17.52 ± 6.09 | |
AD | 16.69 ± 5.58 | |
Region of residence | <0.001* | |
Rural | 19.16 ± 6.47 | |
Urban | 16.91 ± 5.74 | |
Occupation | <0.001* | |
Groups 4, 5 and 6 (outdoor) | 19.22 ± 6.48 | |
Groups 1,2,3, and 7 (indoor) | 16.73 ± 5.73 | |
Sunlight exposure time (h) | <0.001* | |
≥5 | 20.16 ± 6.55 | |
2–5 | 17.83 ± 6.12 | |
<2 | 16.77 ± 5.78 | |
Regular exercise | <0.001* | |
No | 17.31 ± 5.99 | |
Yes | 18.66 ± 6.46 | |
Walking exercise | <0.001* | |
No | 17.25 ± 5.60 | |
Yes | 17.71 ± 6.16 | |
Serum zinc levels (μg/dL) | <0.001* | |
≥110 | 18.61 ± 6.49 | |
<110 | 16.78 ± 5.81 |
* statistically significant by independent t-test
DES = dry eye syndrome; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
Factors associated with developing DES
Table 4 shows the binary logistic regression analysis between dgDES and sxDES and potential risk factors adjusted for age and gender. The analysis showed that dgDES was associated with urban residence (OR, 1.669; 95% CI, 1.456–1.913), indoor occupation (OR, 1.587; 95% CI, 1.389–1.815), depression (OR, 1.059; 95% CI, 1.008–1.113), history of ocular surgery (OR, 1.203; 95% CI, 1.103–1.312), low serum 25(OH)D level (OR, 1.158; 95% CI, 1.026–1.308), and inadequate sunlight exposure time (OR, 1.554; 1.307–1.848). Further, it showed that sxDES was associated with urban residence (OR, 1.243; 95% CI, 1.122–1.377), indoor occupation (OR, 1.264; 95% CI, 1.143–1.399), obesity (OR, 1.115; 95% CI, 1.008–1.232), depression (OR, 1.075; 95% CI, 1.032–1.120), thyroid disease (OR, 1.046; 95% CI, 1.001–1.094), history of ocular surgery (OR, 1.070; 95% CI, 1.011–1.131), and regular exercise (OR, 0.843; 95% CI, 0.724–0.982).
Table 4. Factors that affect the occurrence of dry eye syndrome after adjusting for age and gender.
Diagnosed DES | Symptoms of DES | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Region of residence | ||||||
Rural | 1.0 (ref) | 1.0 (ref) | ||||
Urban | 1.669 | 1.456–1.913 | <0.001* | 1.243 | 1.122–1.377 | <0.001* |
Occupation | ||||||
Outdoor | 1.0 (ref) | 1.0 (Ref) | ||||
Indoor | 1.587 | 1.389–1.815 | <0.001* | 1.264 | 1.143–1.399 | <0.001* |
Obesity | ||||||
Non-obese | 1.0 (ref) | 1.0 (ref) | ||||
Obese | 1.069 | 0.944–1.210 | 0.291 | 1.115 | 1.008–1.232 | 0.034* |
Diabetes mellitus | ||||||
Non-DM | 1.0 (ref) | 1.0 (ref) | ||||
IFG | 1.067 | 0.929–1.224 | 0.359 | 1.075 | 0.962–1.202 | 0.200 |
DM | 0.955 | 0.796–1.145 | 0.618 | 0.998 | 0.864–1.155 | 0.984 |
Rheumatoid arthritis | ||||||
Non-RA | 1.0 (ref) | 1.0 (ref) | ||||
RA | 1.026 | 0.969–1.085 | 0.380 | 1.025 | 0.978–1.074 | 0.299 |
Depression | ||||||
Non-depression | 1.0 (ref) | 1.0 (ref) | ||||
Depression | 1.059 | 1.008–1.113 | 0.024* | 1.075 | 1.032–1.120 | 0.001* |
Thyroid disorder | ||||||
Non-thyroid disorder | 1.0 (ref) | 1.0 (ref) | ||||
Thyroid disorder | 1.053 | 1.000–1.109 | 0.051 | 1.046 | 1.001–1.094 | 0.045* |
History of ocular surgery | ||||||
No | 1.0 (ref) | 1.0 (ref) | ||||
Yes | 1.203 | 1.103–1.312 | <0.001* | 1.070 | 1.011–1.131 | 0.019* |
Atopic dermatitis | ||||||
Non-AD | 1.0 (ref) | 1.0 (ref) | ||||
AD | 1.124 | 0.888–1.423 | 0.330 | 1.199 | 0.994–1.446 | 0.058 |
Sun exposure time (h) | ||||||
Sufficient (≥2) | 1.0 (ref) | 1.0 (ref) | ||||
Inadequate (2–5) | 1.389 | 1.143–1.690 | 0.001* | 1.047 | 0.907–1.209 | 0.528 |
Deficient (<2) | 1.630 | 1.367–1.944 | <0.001* | 1.119 | 0.984–1.271 | 0.085 |
Regular exercise | ||||||
No | 1.0 (ref) | 1.0 (ref) | ||||
Yes | 0.841 | 0.696–1.108 | 0.076 | 0.843 | 0.724–0.982 | 0.029* |
Walking exercise | ||||||
No | 1.0 (ref) | 1.0 (ref) | ||||
Yes | 0.959 | 0.865–1.064 | 0.434 | 0.961 | 0.884–1.045 | 0.353 |
Serum 25(OH)D level (ng/mL) | ||||||
Adequate (≥20) | 1.0 (ref) | 1.0 (ref) | ||||
Inadequate (12–20) | 1.167 | 1.030–1.321 | 0.015* | 1.036 | 0.939–1.143 | 0.483 |
Deficient (<12) | 1.205 | 1.031–1.407 | 0.019* | 1.113 | 0.982–1.262 | 0.094 |
Serum zinc level (μg/dL) | ||||||
≥110 | 1.0 (ref) | 1.0 (ref) | ||||
<110 | 0.926 | 0.671–1.278 | 0.638 | 0.798 | 0.620–1.029 | 0.081 |
*statistically significant by logistic regression analysis
DES = dry eye syndrome; OR = odds ratio; CI = Confidence interval; DM = diabetes mellitus; IFG = impaired fasting glucose; RA = rheumatoid arthritis; AD = atopic dermatitis
After adjusting for age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, and occupation, low serum 25(OH)D levels were the risk factors for dgDES, but not for sxDES (OR, 1.105; 95% CI, 1.007–1.213). Inadequate (OR, 1.178; 95% CI, 1.010–1.372) and deficient serum 25(OH)D level (OR, 1.216; 95% CI, 1.007–1.469) were the risk factors for dgDES (Table 5).
Table 5. Relationship of serum 25-hydroxyvitamin D level and dry eye syndrome.
Diagnosed DES | Symptoms of DES | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Sunlight exposure time (h) | ||||||
Sufficient (≥2) | 1.0 (ref) | 1.0 (ref) | ||||
Inadequate (2–5) | 1.142 | 0.882–1.479 | 0.314 | 0.978 | 0.809–1.182 | 0.815 |
Deficient (<2) | 1.383 | 1.094–1.749 | 0.007* | 1.050 | 0.885–1.246 | 0.575 |
Serum 25(OH)D level (ng/mL) | ||||||
Adequate (≥20) | 1.0 (ref) | 1.0 (ref) | ||||
Inadequate (12–20) | 1.178 | 1.010–1.372 | 0.036* | 1.045 | 0.926–1.179 | 0.475 |
Deficient (<12) | 1.216 | 1.007–1.469 | 0.043* | 1.115 | 0.957–1.298 | 0.163 |
Adjusted by age, sex, obesity, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, occupation and residence. 25-hydroxyvitamin D = 25(OH)D; DES = dry eye syndrome; OR = odds ratio; CI = Confidence interval
*statistically significant by logistic regression analysis
Discussion
DES is a common ocular disease in the general population and affects vision-related quality of life [1,30]. DES has been associated with various factors [7,30]. However, the associations between serum 25(OH)D levels and DES or between sunlight exposure time and DES have not been investigated.
In this study, we found that older age, female gender, rheumatoid arthritis, depression, thyroid disorder, history of ocular surgery, urban residence, indoor occupation, inadequate sunlight exposure, and low serum 25(OH)D level were the risk factor for dgDES. Older age and female gender are relatively well-known risk factors [6,7]. Aging, which is an important risk factor for DES, has been reported to be associated with lacrimal dysfunction [31]. Low estrogen levels after menopause in women have been described as being a major contributing factor for DES [32]. Androgen, estrogen, and progesterone receptor mRNAs have been identified in the eye [32]. Sex hormones are known to influence the immune system, and estrogen itself may modulate a cascade of inflammatory events that underlie DES [33]. Rheumatoid arthritis, depression, thyroid disorder, and history of ocular surgery are the well-known risk factors for DES [5–9,26]. DES is a common ocular manifestation in rheumatoid arthritis patients even though the severity of DES is independent of rheumatoid arthritis activity [34]. The association of DES and Graves’ ophthalmopathy have been described to suggest the mechanical impairment of orbital muscles and immune-mediated lacrimal gland dysfunction [35]. Depression is not only a risk factor for DES but anticholinergic effects of anti-depressant also can induce DES [36]. Ocular surgery induces the changes in corneal innervation which play an essential role in the pathogenesis of dry eye syndrome [37].
Urban residence and indoor occupation were the risk factors for dgDES and sxDES. In previous studies, urban dwellers and subjects with indoor occupations were reported to be factors associated with DES [8,38,39]. They have been described to be due to low indoor humidity [40], air pollution [9,41], and visual display terminal (VDT) syndrome, which is accompanied by lower blinking rates and increased tear evaporation [42]. However, the reason for the prevalence of DES in urban residency and among those with indoor occupations has not been understood thoroughly. We noticed that the participants with both urban residence and indoor occupations were exposed to sunlight inadequately. Thus, we evaluated the associations between sunlight exposure time and dgDES or sxDES. We found that inadequate sunlight exposure time (<5 h) was a risk factor for dgDES, but not for sxDES. It has been reported that sunlight exposure should be avoided, because it contributes to an increased risk of dry age-related macular degeneration, cataract, and pterygium [43]. However, sunlight exposure has been reported to prevent the development of myopia [44], depression [45,46], anxiety [16,47], diabetes [15], and autoimmune disease [48]. Sunlight exposure is by far the most important source of vitamin D [15,49]. The human skin has a large capacity for vitamin D production [49]. Vitamin D3 is synthesized in the skin from 7-dehydrocholesterol under the influence of UV-B (wavelength, 290–315 nm) radiation and temperature [50]. In this study, serum 25(OH)D levels were lower in DES compared to non-DES. After adjusting for age and gender, inadequate serum 25(OH)D levels (<20 ng/mL) were a risk factor with dgDES. However, sxDES was associated only with deficient serum 25(OH)D levels (<12 ng/mL), not with inadequate levels (<20 ng/mL). Vitamin D receptor has been reported to exist in ocular barrier cells [18]. It has been suggested that vitamin D might have a role in immune regulation and barrier function in ocular barrier epithelial cells [18]. Vitamin D has been reported to enhance corneal epithelial barrier function [51] through regulating gap junctions [52] and tight junction [53]. Vitamin D exerts an immunomodulating effect on the immune system [14]. In mice, vitamin D has been shown to suppress ocular surface inflammation by inhibiting Langerhans cell migration into corneas [54], thus inhibiting corneal neovascularization [55]. Furthermore, salivary glands and their epithelial and myoepithelial cells are major vitamin D targets [19], and fluid and electrolyte secretion from the parotid gland is dependent on vitamin D directly [20]. Thus, lacrimal glands as well as corneal epithelial cells also may be affected by vitamin D. It has been reported that vitamin D deficiency is prevalent in patients with Sjogren's syndrome and that female patients with Sjogren's syndrome are at risk for vitamin D deficiency [56].
In this study, we evaluated the effect of exercise on DES. After adjusting for age and gender, regular and walking exercise did not affect dgDES. However, regular exercise was a protective factor for sxDES. Regular exercise has an acute effect on salivary hormone response [57]. Regular exercise may be helpful in reducing symptoms in patients with DES. Serum zinc levels, in this study, were lower in sxDES group compared to non-sxDES group. Zinc has a role in retinal metabolism and may be beneficial in macular degeneration [58]. Zinc ion-dependent B-cell epitope is associated with primary Sjogren's syndrome [59]. However, after adjusting for age and gender, serum zinc levels did not affect sxDES. The discrepancy between the sunlight exposure and serum 25(OH)D level has been reported [60]. Serum vitamin D status can be remained despite abundant sun exposure [60]. Vitamin D obtained from the diet or cutaneous synthesis is readily taken up by adipose tissue [61]. Bioavailability of vitamin D has been reported to be reduced in obesity [62]. Thus, obesity should be considered as an confounding factor for evaluation of the effect of vitamin D. After adjusting age, gender, diabetes mellitus, rheumatoid arthritis, depression, thyroid disorder, atopic dermatitis, history of ocular surgery, regular exercise, obesity, and occupation, deficient sunlight exposure and inadequate and deficient serum 25(OH)D levels were a risk factor for DES.
In conclusion, deficient sunlight exposure time and inadequate serum 25(OH)D levels are associated with DES in Korean adults. These results suggest that sufficient sunlight exposure and/or vitamin D supplementation may be helpful in treatment of DES.
Supporting Information
Acknowledgments
This study was supported by the National Research Foundation (NRF) grant (NRF-2015R1D1A1A09058505) funded by the Korea government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data Availability
Data are available from the Korea Center for Chronic Disease and Control Institutional Data Access / Ethics Committee for researchers who meet the criteria for access to confidential data. The authors obtained the data set from the Korea Center for Chronic Disease and Control, which owns the data. Readers can send requests for data to Tel: 82-43-719-7466 or Email: choym527@korea.kr (Division of Health and Nutrition Survey, KCDC) or Osong Health Technology Administration Complex, 187 Osongsaengmyeong2(i)-ro, Osong-eup, Heungduk-gu, Cheongju-si, Chungcheongbuk-do, Korea 363-700.
Funding Statement
This study was supported by the National Research Foundation (NRF) grant (NRF-2015R1D1A1A09058505) funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf 2007;5:75–92. [DOI] [PubMed] [Google Scholar]
- 2.Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf 2006; 4:155–61. [DOI] [PubMed] [Google Scholar]
- 3.Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune mediated ocular surface disorder. Arch Ophthalmol 2012; 130:90–100. 10.1001/archophthalmol.2011.364 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostastic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 2012; 31:271–285. 10.1016/j.preteyeres.2012.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol 2014;98:1712–7. 10.1136/bjophthalmol-2014-305201 [DOI] [PubMed] [Google Scholar]
- 6.Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 2002;86:1347–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002;506:989–998. [DOI] [PubMed] [Google Scholar]
- 8.Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, Kim KW. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol 2011;129:633–8. 10.1001/archophthalmol.2011.78 [DOI] [PubMed] [Google Scholar]
- 9.Galor A, Kumar N, Feuer W, Lee DJ. Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology 2014;121:972–3. 10.1016/j.ophtha.2013.11.036 [DOI] [PubMed] [Google Scholar]
- 10.Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81. [DOI] [PubMed] [Google Scholar]
- 11.Rhee SY, Hwang YC, Chung HY, Woo JT. Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2009. Diabet Med 2012;29:1003–10. 10.1111/j.1464-5491.2012.03575.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, et al. Vitamin D insufficiency in Korea–a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011;96:643–51. 10.1210/jc.2010-2133 [DOI] [PubMed] [Google Scholar]
- 13.Nam GE, Kim DH, Cho KH, Park YG, Han KD, Kim SM, et al. 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008–2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr 2014;17:186–94. 10.1017/S1368980012004855 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cheng HM, Kim S, Park GH, Chang SE, Bang S, Won CH, et al. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol 2014;133:1048–55. 10.1016/j.jaci.2013.10.055 [DOI] [PubMed] [Google Scholar]
- 15.Geldenhuys S, Hart PH, Endersby R, Jacoby P, Feelisch M, Weller RB, et al. Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes 2014;63:3759–69. 10.2337/db13-1675 [DOI] [PubMed] [Google Scholar]
- 16.Mosher CE, Danoff-Burg S. Addiction to indoor tanning: relation to anxiety, depression, and substance use. Arch Dermatol 2010;146:412–7. 10.1001/archdermatol.2009.385 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Berridge MJ. Vitamin D cell signalling in health and disease. Biochem Biophys Res Commun 2015;460:53–71. 10.1016/j.bbrc.2015.01.008 [DOI] [PubMed] [Google Scholar]
- 18.Alsalem JA, Patel D, Susarla R, Coca-Prados M, Bland R, Walker EA, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci 2014;55:2140–7. 10.1167/iovs.13-13019 [DOI] [PubMed] [Google Scholar]
- 19.Stumpf WE, Hayakawa N. Salivary glands epithelial and myoepithelial cells are major vitamin D targets. Eur J Drug Metab Pharmacokinet 2007;32:123–9. [DOI] [PubMed] [Google Scholar]
- 20.Peterfy C, Tenenhouse A, Yu E. Vitamin D and parotid gland function in the rat. J Physiol 1988;398:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kramer C, Seltmann H, Seifert M, Tilgen W, Zouboulis CC, Reichrath J. Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol 2009;113:9–16. 10.1016/j.jsbmb.2008.10.010 [DOI] [PubMed] [Google Scholar]
- 22.Muehleisen B, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol 2013;131:324–9. 10.1016/j.jaci.2012.12.1562 [DOI] [PubMed] [Google Scholar]
- 23.Consiglio M, Viano M, Casarin S, Castagnoli C, Pescarmona G, Silvagno F. Mitochondrial and lipogenic effects of vitamin D in differentiating and proliferating human keratinocytes. Exp Dermatol 2015. May 23. [DOI] [PubMed] [Google Scholar]
- 24.Galor A, Gardener H, Pouyeh B, Feuer W, Florez H. Effect of a Mediterranean dietary pattern and vitamin D levels on Dry Eye syndrome. Cornea. 2014;33:437–41. 10.1097/ICO.0000000000000089 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kurtul BE, Özer PA, Aydinli MS. The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögrendry eye. Eye (Lond). 2015;29:1081–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ahn JM, Lee SH, Rim TH, Park RJ, Yang HS, Kim TI, et al. Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010–2011. Am J Ophthalmol 2014;158:1205–1214. 10.1016/j.ajo.2014.08.021 [DOI] [PubMed] [Google Scholar]
- 27.Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care. 2007;30:228–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Institute of Medicine of the National Academies. Dietary reference intakes for calcium and vitamin D Washington, DC: The National Academies Press; 2010. [Google Scholar]
- 29.Choi CJ, Seo M, Choi WS, Kim KS, Youn SA, Lindsey T, et al. Relationship between serum 25-hydroxyvitamin D and lung function among Korean adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2010. J Clin Endocrinol Metab 2013;98:1703–10. 10.1210/jc.2012-3901 [DOI] [PubMed] [Google Scholar]
- 30.Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kawashima M, Kawakita T, Inaba T, Okada N, Ito M, Shimmura S, et al. Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice. PLoS One 2012;7:e33148 10.1371/journal.pone.0033148 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78:146–53. [DOI] [PubMed] [Google Scholar]
- 33.Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exp Optom 2014;97:324–36. 10.1111/cxo.12147 [DOI] [PubMed] [Google Scholar]
- 34.Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005;140:808–13. [DOI] [PubMed] [Google Scholar]
- 35.Selter JH, Gire AI, Sikder S. The relationship between Graves' ophthalmopathy and dry eye syndrome. Clin Ophthalmol 2014;9:57–62. 10.2147/OPTH.S76583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wong J, Lan W, Ong LM, Tong L. Non-hormonal systemic medications and dry eye. Ocul Surf 2011;9212–26. [DOI] [PubMed] [Google Scholar]
- 37.Chao C, Golebiowski B, Stapleton F. The role of corneal innervation in LASIK-induced neuropathic dry eye. Ocul Surf 2014;12:32–45. 10.1016/j.jtos.2013.09.001 [DOI] [PubMed] [Google Scholar]
- 38.Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond) 2009;23:688–93. [DOI] [PubMed] [Google Scholar]
- 39.Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002;133:181–186. [DOI] [PubMed] [Google Scholar]
- 40.Wolkoff P, Kjaergaard SK. The dichotomy of relative humidity on indoor air quality. Environ Int 2007;33:850–7. [DOI] [PubMed] [Google Scholar]
- 41.Lois N, Abdelkader E, Reglitz K, Garden C, Ayres JG. Environmental tobacco smoke exposure and eye disease. Br J Ophthalmol 2008;92:1304–10. 10.1136/bjo.2008.141168 [DOI] [PubMed] [Google Scholar]
- 42.Uchino M, Schaumberg DA, Dogru M, Uchino Y, Fukagawa K, Shimmura S, et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008;115:1982–8. 10.1016/j.ophtha.2008.06.022 [DOI] [PubMed] [Google Scholar]
- 43.Dolin PJ, Johnson GJ. Solar ultraviolet radiation and ocular disease: a review of the epidemiological and experimental evidence. Ophthalmic Epidemiol 1994;1:155–64. [DOI] [PubMed] [Google Scholar]
- 44.Wang Y, Ding H, Stell WK, Liu L, Li S, Liu H, et al. Exposure to sunlight reduces the risk of myopia in rhesus monkeys. PLoS One 2015;10:e0127863 10.1371/journal.pone.0127863 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Vyssoki B, Kapusta ND, Praschak-Rieder N, Dorffner G, Willeit M. Direct effect of sunshine on suicide. JAMA Psychiatry 2014;71:1231–7. 10.1001/jamapsychiatry.2014.1198 [DOI] [PubMed] [Google Scholar]
- 46.Axelsson J, Ragnarsdóttir S, Pind J, Sigbjörnsson R. Daylight availability: a poor predictor of depression in Iceland. Int J Circumpolar Health 2004;63:267–76. [DOI] [PubMed] [Google Scholar]
- 47.Doganay Z, Sunter AT, Guz H, Ozkan A, Altintop L, Kati C, et al. Climatic and diurnal variation in suicide attempts in the ED. Am J Emerg Med 2003;21:271–5. [DOI] [PubMed] [Google Scholar]
- 48.Lucas RM, Ponsonby AL. Considering the potential benefits as well as adverse effects of sun exposure: can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol 2006;92:140–9. [DOI] [PubMed] [Google Scholar]
- 49.Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25- hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990; 51: 1075 81. [DOI] [PubMed] [Google Scholar]
- 50.Lo CW, Paris PW, Holick MF. Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr 1986; 44: 683–85. [DOI] [PubMed] [Google Scholar]
- 51.Yin Z, Pintea V, Lin Y, Hammock BD, Watsky MA. Vitamin D enhances corneal epithelial barrier function. Invest Ophthalmol Vis Sci 2011;52:7359–64. 10.1167/iovs.11-7605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lu X, Watsky MA. Effects of vitamin D receptor knockout on cornea epithelium gap junctions. Invest Ophthalmol Vis Sci 2014;55:2975–82. 10.1167/iovs.13-13788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Elizondo RA, Yin Z, Lu X, Watsky MA. Effect of vitamin D receptor knockout on cornea epithelium wound healing and tight junctions. Invest Ophthalmol Vis Sci 2014;55:5245–51. 10.1167/iovs.13-13553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Suzuki T, Sano Y, Kinoshita S. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci 2000;41:154–8. [PubMed] [Google Scholar]
- 55.Suzuki T, Sano Y, Sotozono C, Kinoshita S. Regulatory effects of 1alpha,25-dihydroxyvitamin D(3) on cytokine production by human corneal epithelial cells. Curr Eye Res 2000;20:127–30. [PubMed] [Google Scholar]
- 56.Erten Ş, Şahin A, Altunoğlu A, Gemcioğlu E, Koca C. Comparison of plasma vitamin D levels in patients with Sjögren's syndrome and healthy subjects. Int J Rheum Dis 2015; 18:70–5. 10.1111/1756-185X.12298 [DOI] [PubMed] [Google Scholar]
- 57.Beaven CM, Gill ND, Ingram JR, Hopkins WG. Acute salivary hormone responses to complex exercise bouts. J Strength Cond Res 2011;25:1072–8. 10.1519/JSC.0b013e3181bf4414 [DOI] [PubMed] [Google Scholar]
- 58.Brown NA, Bron AJ, Harding JJ, Dewar HM. Nutrition supplements and the eye. Eye (Lond) 1998;12 (Pt 1):127–33. [DOI] [PubMed] [Google Scholar]
- 59.Routsias JG, Kosmopoulou A, Makri A, Panou-Pomonis E, Sakarellos C, Sakarellos-Daitsiotis M, et al. Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J Med Chem 2004;47:4327–34. [DOI] [PubMed] [Google Scholar]
- 60.Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007;92:2130–5. [DOI] [PubMed] [Google Scholar]
- 61.Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33: 90–94. 10.1007/s12020-008-9051-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690–3. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data are available from the Korea Center for Chronic Disease and Control Institutional Data Access / Ethics Committee for researchers who meet the criteria for access to confidential data. The authors obtained the data set from the Korea Center for Chronic Disease and Control, which owns the data. Readers can send requests for data to Tel: 82-43-719-7466 or Email: choym527@korea.kr (Division of Health and Nutrition Survey, KCDC) or Osong Health Technology Administration Complex, 187 Osongsaengmyeong2(i)-ro, Osong-eup, Heungduk-gu, Cheongju-si, Chungcheongbuk-do, Korea 363-700.